After some six years at the post, Amgen’s finance chief is telegraphing his exit from the California pharma by early next year. | After some six years at the post, Amgen’s finance chief is telegraphing his exit from the California pharma by early next year.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug
Ascension triples net income, slims operating margin to -1.1% across 9 months
Fierce Healthcare Layoff Tracker—Innovaccer lays off 340 employees; Cuts at HCA Healthcare
Supply costs, payer challenges drag CommonSpirit Health to -5.8% operating margin in fiscal Q3
Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer
Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026
Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal…
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at…
With a new CEO prepared to take the reins next month and three key launches on deck for 2026 and 2027, Takeda is ready to shake…
A Novartis cross-border partnership is turning into a standoff. | A Novartis cross-border partnership is turning into a standoff.…
After doubling sales of its Biogen-partnered Alzheimer’s disease med Leqembi in its 2025 fiscal year, Eisai figures the crawl to…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
